Today's Daily Dose brings you news about Advaxis' upcoming presentation; Deciphera's date with FDA and Trovagene's update on its phase II study of Onvansertib in metastatic castrate-resistant prostate cancer.
from RTT - Biotech https://ift.tt/39yPWq3
via IFTTT
No comments:
Post a Comment